COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
07 07 2020
Historique:
received: 04 04 2020
revised: 13 04 2020
accepted: 13 04 2020
pubmed: 20 4 2020
medline: 14 7 2020
entrez: 20 4 2020
Statut: ppublish

Résumé

The COVID-19 pandemic has presented a major unanticipated stress on the workforce, organizational structure, systems of care, and critical resource supplies. To ensure provider safety, to maximize efficiency, and to optimize patient outcomes, health systems need to be agile. Critical care cardiologists may be uniquely positioned to treat the numerous respiratory and cardiovascular complications of the SARS-CoV-2 and support clinicians without critical care training who may be suddenly asked to care for critically ill patients. This review draws upon the experiences of colleagues from heavily impacted regions of the United States and Europe, as well as lessons learned from military mass casualty medicine. This review offers pragmatic suggestions on how to implement scalable models for critical care delivery, cultivate educational tools for team training, and embrace technologies (e.g., telemedicine) to enable effective collaboration despite social distancing imperatives.

Identifiants

pubmed: 32305402
pii: S0735-1097(20)35002-6
doi: 10.1016/j.jacc.2020.04.029
pmc: PMC7161519
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-84

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR001864
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. All rights reserved.

Références

Eur Heart J. 2020 May 14;41(19):1798-1800
pubmed: 32186331
Circulation. 2004 Jun 8;109(22):2737-43
pubmed: 15159293
JAMA Cardiol. 2020 Jul 1;5(7):811-818
pubmed: 32219356
J Am Heart Assoc. 2019 Mar 19;8(6):e011721
pubmed: 30879373
Circ Cardiovasc Qual Outcomes. 2017 Aug;10(8):e003616
pubmed: 28794121
Echocardiography. 2019 Apr;36(4):631-638
pubmed: 30969477
Crit Care Med. 2010 Feb;38(2):375-81
pubmed: 20029344
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
JAMA Cardiol. 2020 Jul 1;5(7):819-824
pubmed: 32219357
N Engl J Med. 2006 Dec 28;355(26):2725-32
pubmed: 17192537
Crit Care. 2020 Mar 18;24(1):108
pubmed: 32188484
J Am Heart Assoc. 2018 Mar 10;7(6):
pubmed: 29525785
J Gen Intern Med. 2020 May;35(5):1545-1549
pubmed: 32133578
CMAJ. 2006 Nov 21;175(11):1377-81
pubmed: 17116904
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
Circulation. 2020 Mar 10;141(10):e615-e644
pubmed: 32078375
Circulation. 2020 May 19;141(20):e810-e816
pubmed: 32216640
Circulation. 2007 Jul 10;116(2):217-30
pubmed: 17538045
JAMA Cardiol. 2019 Sep 1;4(9):928-935
pubmed: 31339509
Circulation. 2019 Jul 23;140(4):267-269
pubmed: 31329487
Crit Care. 2012 Dec 12;16(2):R68
pubmed: 22541022
Chest. 2019 Dec;156(6):1223-1233
pubmed: 31374210
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Crit Care. 2020 Mar 9;24(1):83
pubmed: 32151274
Minerva Cardioangiol. 2020 Apr;68(2):61-64
pubmed: 32150358
Chest. 2014 Oct;146(4 Suppl):e61S-74S
pubmed: 25144591
BMC Health Serv Res. 2018 Nov 6;18(1):831
pubmed: 30400985
J Am Coll Cardiol. 2007 Aug 14;50(7):e1-e157
pubmed: 17692738
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375
pubmed: 32199938
Circulation. 2017 Oct 17;136(16):e232-e268
pubmed: 28923988
Circ Cardiovasc Qual Outcomes. 2010 Jul;3(4):424-30
pubmed: 20647576
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
JACC Cardiovasc Interv. 2019 Apr 22;12(8):709-717
pubmed: 31000008
JAMA. 2020 May 12;323(18):1773-1774
pubmed: 32219367
Am J Disaster Med. 2009 Nov-Dec;4(6):321-9
pubmed: 20104725
Chest. 2008 May;133(5 Suppl):51S-66S
pubmed: 18460506
Mil Med. 1990 Apr;155(4):152-5
pubmed: 2110334
Circulation. 2016 Oct 18;134(16):1189-1191
pubmed: 27754948
Circulation. 2012 Sep 11;126(11):1408-28
pubmed: 22893607
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131

Auteurs

Jason N Katz (JN)

Division of Cardiology, Duke University, Durham, North Carolina. Electronic address: jason.katz@duke.edu.

Shashank S Sinha (SS)

Inova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, Virginia. Electronic address: https://twitter.com/ShashankSinhaMD.

Carlos L Alviar (CL)

Leon H. Charney Division of Cardiology, New York University Langone Medical Center NYU Langone Medical Center, New York, New York.

David M Dudzinski (DM)

Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts.

Ann Gage (A)

Division of Cardiology, Cleveland Clinic, Cleveland, Ohio.

Samuel B Brusca (SB)

Critical Care Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland.

M Casey Flanagan (MC)

Inova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, Virginia.

Timothy Welch (T)

Inova Heart and Vascular Institute, Inova Fairfax Medical Center, Falls Church, Virginia; Virginia Heart, Falls Church, Virginia.

Bram J Geller (BJ)

Division of Cardiology, Maine Medical Center, Portland, Maine.

P Elliott Miller (PE)

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.

Sergio Leonardi (S)

Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology-Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Erin A Bohula (EA)

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Susanna Price (S)

Royal Brompton and Harefield NHS Foundation Trust, Royal Brompton Hospital, London, United Kingdom.

Sunit-Preet Chaudhry (SP)

Department of Cardiology, St. Vincent Hospital, Indianapolis, Indiana.

Thomas S Metkus (TS)

Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Connor G O'Brien (CG)

Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, California.

Alessandro Sionis (A)

Intensive Cardiac Care Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute IIB-SantPaul, Universidad Autonoma de Barcelona, Barcelona, Spain.

Christopher F Barnett (CF)

Department of Cardiology, Medstar Washington Hospital Center, Washington, DC.

Jacob C Jentzer (JC)

Department of Cardiovascular Medicine and Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota.

Michael A Solomon (MA)

Critical Care Medicine, National Institutes of Health Clinical Center, Bethesda, Maryland; Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

David A Morrow (DA)

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Sean van Diepen (S)

Department of Critical Care and Division of Cardiology, Department of Medicine, University of Alberta Hospital, Alberta, Canada. Electronic address: https://twitter.com/seanvandiepen.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH